PIVKA-II as a potential new biomarker for hepatocellular carcinoma–a pilot study

S Svobodova, M Karlikova, O Topolcan, L Pecen… - in vivo, 2018 - iv.iiarjournals.org
Aim: The aim of this study was to evaluate the clinical contribution of protein induced by
vitamin K absence (PIVKA-II) for hepatocellular carcinoma (HCC) diagnostics and compare it …

Evaluation of IL-2, IL-6, IL-8 and IL-10 in malignant melanoma diagnostics

…, J Windrichova, R Fuchsova, S Svobodova… - Anticancer …, 2015 - ar.iiarjournals.org
Aim: The aim of the present study was to evaluate the usefulness of four interleukins (IL-2, IL-6,
IL-8 and IL-10) for melanoma detection and correlate these interleukins with sentinel …

Phylogeny, life history evolution and biogeography of the Rhinanthoid Orobanchaceae

J Těšitel, P Říha, Š Svobodová, T Malinová, M Štech - Folia Geobotanica, 2010 - Springer
Rhinanthoid Orobanchaceae form a monophyletic lineage that include the hemiparasitic
genera Euphrasia, Melampyrum, Tozzia, Bartsia, Nothobartsia, Odontites (sl), Rhinanthus, …

Evaluation of IGF1 serum levels in malignant melanoma and healthy subjects

…, I Treskova, J Vrzalova, S Svobodova… - Anticancer …, 2014 - ar.iiarjournals.org
Background/Aim: There were two aims in the present study. The first was to evaluate the
usefulness of insulin-like growth factor 1 (IGF1) for melanoma detection. The second was to …

Reference values of IGF1, IGFBP3 and IGF1/IGFBP3 ratio in adult population in the Czech Republic

…, O Topolcan, L Pecen, J Kinkorova, S Svobodova… - Clinica chimica acta, 2015 - Elsevier
Background IGF1 is responsible for regulation of growth, metabolism and differentiation of
human cells. IGFBP3 is the most abundant of the carrier proteins for IGF1 in the blood. IGF1/…

Parameters of biological activity in colorectal cancer

S Svobodova, O Topolcan, L HOLUBEC… - Anticancer …, 2011 - ar.iiarjournals.org
Background: The aim of this study was to measure several parameters in patients with early-stage
colorectal cancer (CRC) and to evaluate them for their utility in routine clinical practice…

CEA, CA 15-3, and TPS as prognostic factors in the follow-up monitoring of patients after radical surgery for breast cancer

S Svobodova, R Kucera, O Fiala, M Karlikova… - Anticancer …, 2018 - ar.iiarjournals.org
Aim: The aim of this study was to evaluate the ability of tissue polypeptide-specific antigen (TPS),
carcinoembryonic antigen (CEA), and cancer antigen 15-3 (CA 15-3) to predict relapse …

Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study

P Pazdiora, S Svobodova, R Fuchsova… - Anticancer …, 2011 - ar.iiarjournals.org
Background: Many studies have demonstrated the relationship between vitamin D and
cancer of many different sites, including of the breast, colorectum, prostate and lung. Most …

Growth factors and breast tumors, comparison of selected growth factors with traditional tumor markers

…, M Cerna, A Narsanska, S Svobodova… - Anticancer …, 2011 - ar.iiarjournals.org
Background: The first aim of this project was to study new possibilities for distinguishing
benign from malignant tumors using growth factors and to compare them with the traditional …

CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management

…, J Vrzalova, L Betincova, S Svobodova - Anticancer …, 2014 - ar.iiarjournals.org
Aim: The aim of the present study was to compare the use of cancer antigen 125 (CA125)
and human epididymis protein 4 (HE4) biomarkers in patients with endometrial cancer for …